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Abstract
Gadupudi, Gopi S. MS. The University of Memphis. August 2011. Evidence for
Genotoxicity of 3-Hydroxyanthranilic Acid in the Presence of a Metal Cofactor Copper
In Vitro. Major Professor: King-Thom Chung. PhD.
Tryptophan metabolites anthranilic acid (AA) and 3-hydroxyanthranilic acid
(3-OHAA) have been implicated in the etiology of bladder cancer. Metal-mediated
activation of these compounds into mutagens was tested using a plasmid relaxation assay
at increasing concentrations of copper (Cu (II)) at 5 µM-20 µM in the presence of
plasmid pSP-72. One hundred µM 3-OHAA induced plasmid relaxation in the presence
of metal cofactor Cu (II) at a concentration as low as 5 µM. The Cu (II) mediated
mutagenic activation of 3-OHAA was further investigated using Ames
Salmonella/microsome mutagenicity assay with the reactive oxygen species
(ROS) sensitive tester strain Salmonella TA102. A significant increase in TA102
revertants was observed with an increase in concentration of Cu (II) from 2.5 µg to 50 µg
incubated with 100 µg 3-OHAA/plate but not AA. This evidence for mutagenicity with
only 3-OHAA in the presence of Cu (II) but not with AA suggests that the presence of
the hydroxyl group in 3-OHAA is critical for generating ROS mediated mutagenicity. In
summary, this study finds that 3-OHAA, in the presence of the metal cofactor copper
causes oxidative stress that damages DNA.
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Preface
This manuscript was written and intended to be submitted for publication in the
journal Environmental and Molecular Mutagenesis. Additionally, two sections that
include the introduction explaining the rationale behind this work and conclusion
discussing the significance of this work were appended for better understanding.
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Chapter 1
Introduction
Bladder cancer is ranked as the ninth most prominent cause of cancer and ranked
thirteenth in number of deaths caused by cancer [Parkin, 2008]. Harvard Men’s health
Watch [2011] reported that in The USA bladder cancer is more prevalent in men than
women. It is ranked as the fourth most common cause of cancer among men. Various
factors that include cigarette smoking, occupational exposure to industrial aromatic
amines, and dietary factors are attributed to the cause of bladder cancer [Gazdar, 2001;
Pelucchi et al., 2006]. Pavanello et al. [2007] reported that the urine collected from the
urinary bladder of non-smokers after overnight retention displayed mutagenic activity.
They have attributed that the cause to the consumption of diet with high mutagenic
content and accumulation of mutagenic metabolites in their urine.
Benassi et al. [1963] reported that there was an increase in the excretion of
tryptophan metabolites in patients suffering from bladder cancer and urological diseases.
Teulings et al. [1978] reported that bladder cancer patients have excreted particularly
high concentrations of 3-hydroxyanthranilic acid (3-OHAA) and 3-hydroxykynurenine
(3-OHKN) excreted in their urine. Kerr et al. [1964] noticed an interesting structural
similarity of 3-OHAA and 3-OHKN with a known bladder carcinogen 2-naphthylamine.
They have both amino and hydroxyl groups at the ortho position to each other, and hence
classified as ortho-amino phenols. Bryan et al. [1971] reported that cholesterol implants
of 3-OHAA, 3-OHKN, and anthranilic acid (AA) in the urinary bladders of mice caused
bladder tumors. Teulings et al. [1975] reported that untreated bladder and kidney
carcinoma patients excreted high amounts of unconjugated 3-OHAA in their urine when
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compared to the healthy individuals. Several other reports from animal models suspected
the role of the tryptophan metabolites as a cause of bladder cancer have been reviewed by
Chung and Gadupudi [2011].
Kawanishi et al. [2002] proposed that the metal cofactors such as the iron (Fe
(II)), copper (Cu (II)), and manganese (Mn (III)) present in the human body would
interact with various metabolites generated from xenobiotic compounds or endogenous
compounds, produce reactive oxygen species (ROS) and cause mutagenesis. Fe (II) in the
presence of a tryptophan metabolite serotonin was reported to cause DNA damage by
generating hydroxyl radicals (OH-) [Hadi et al., 2002]. Cu (II) in the presence of L-Dopa,
a precursor of dopamine, caused DNA adducts in the brain tissue [Spencer et al., 1994].
Recently, Mazdak et al. [2011] reported increased copper concentration in the serum of
bladder cancer patients.
Because of the above reports, the current study demonstrates the ability of
tryptophan metabolites AA and 3-OHAA to cause mutagenesis. We also evaluated the
role of metal cofactors, particularly Cu (II), in activating the tryptophan metabolites AA
and 3-OHAA to mutagens in vitro. The possibility of rat liver S9 fraction would detoxify
the mutagenicity of AA and 3-OHAA was also tested and discussed.
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Chapter 2
Evidence for Genotoxicity of 3-Hydroxyanthranilic Acid but not Anthranilic Acid in
the Presence of a Metal Cofactor Cu (II) In Vitro
Introduction
Tryptophan is an essential amino acid and a precursor for many metabolites
including serotonin, nicotinamide adenosine dinucleotide (NAD), niacin, and indole
acetic acid [Krehl et al., 1945]. The metabolism of tryptophan occurs in the liver and
generates many intermediate metabolites that are involved in liver and bladder
carcinogenesis [Sidransky H, 1997]. Tryptophan is metabolized mainly in three
pathways: serotonin, indole, and kynurenine or NAD pathways. Metabolites anthranilic
acid (AA), 3-hydroxyanthranilic acid (3-OHAA), kynurenine (KN), 3hydroxykynurenine (3-OHKN) generated during NAD synthesis are localized in the liver,
kidney, bladder and are implicated in playing a role in bladder and kidney tumorigenesis.
Recently, a comprehensive review on tryptophan metabolism and its metabolites in
causing bladder tumorigenesis was described by Chung and Gadupudi [2011].
The 3-OHAA is synthesized in the NAD pathway from its precursor 3-OHKN or
KN by kynureninase (L-KN hydrolase, EC 3.7.1.3) in the presence of cofactor vitamin
B6 [Bertazzo et al., 2001; Chung and Gadupudi, 2011]. It has been indicated by clinical
studies that bladder cancer patients secreted a significant increase in basal concentration
of the 3-OHAA in their urine compared to healthy individuals [Teulings et al., 1973;
Teulings et al., 1975]. Another study of ten bladder cancer patients by Boyland and
Williams [1956] reported an increase in excretion of 3-OHAA, AA along with other
tryptophan metabolites KN, and 3-OHKN in their urine. 3-OHAA when implanted in
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mouse bladders on a cholesterol vehicle induced bladder tumors [Allen et al., 1957].
Watanabe et al. [1979] proposed that individual differences in excretion ratio of 3-OHAA
could play a role in the etiology of bladder cancer. Clayson et al. [1958] proposed that
aromatic amines with the hydroxyl group at ortho positon are carcinogenic. These
compounds with both amino and hydroxyl group at ortho postion to each other are called
ortho-aminophenols. The 3-OHAA and 3-OHKN are endogenous ortho-aminophenols
generated in the NAD pathway and excreted in increased amounts by bladder cancer
patients. Additionally, they are also similar in structure to other known bladder
carcinogens like 2-naphthylamine; however the mechanisms involved in causing
carcinogenesis are unknown [Kerr et al., 1965]. Many enzymes in tryptophan metabolism
require vitamin B6 as a cofactor including kynureninase described above for generating
3-OHAA. A deficiency in vitamin B6 would stop further metabolism and accumulate
these metabolites in the bladder and possibly cause carcinogenesis [Kerr et al., 1965; Birt
et al., 1987; Rose DP 1972].
Several endogenous metabolites generated from xenobiotic aromatic
hydrocarbons and biological compounds are able to induce a co-mutagenic effect in the
presence of physiologically available metal cofactors like Mn (III), Cu (II), Zn (II), Fe
(II), by generating reactive oxygen species (ROS) [Kawanishi et al., 2002; Chung and
Gadupudi, 2011; Ando et al., 2011]. Iwahashi et al. [1988] proposed that 3-OHAA in the
presence of Fe (III) is oxidized to generate anthranilyl radical, which later condenses into
cinnabarinic acid that eventually forms DNA adducts. Apparently, reduction of Fe (III) to
Fe (II) by the anthranilyl radical generates fenton chemistry to cause hydroxyl radical
mediated cell damage [Dykens et al., 1987]. The byproduct cinnabarinic acid was also
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reported to cause apoptosis in thymocytes by generating ROS [Hiramatsu et al., 2008].
Another important cofactor Cu (II) is also believed to play a crucial role in the oxidative
stress. Salsolinol, a neurotoxin, in the presence of Cu (II) induced DNA strand breaks in
the calf thymus DNA and caused cell death in PC12 cells by causing oxidative stress
[Kim et al., 1997]. Similarly, L-Dopa, a precursor of dopamine, in the presence of Cu (II)
was able to cause DNA damage in vitro [Husain and Hadi, 1995]. 5-Hydroxytryptamine
in the serotonin pathway was also showed to cause DNA cleavage in vitro possibly by
generating hydroxyl radicals [Hadi et al., 2002]. Aminoacetone and 3-OHAA metabolites
of threonine and tryptophan, respectively in the presence of Cu (II), caused DNA damage
in protoncogene c-Ha-ras-1 [Hiraku et al., 1995; Hiraku et al., 1999].
In the present study, we have evaluated the ability of tryptophan metabolites 3OHAA, AA in the presence metal cofactor Cu (II) to cause mutagenesis. Salmonella
strain TA102 sensitive to oxidative mutagens was employed to check their potency to
cause oxidative stress inside the cell. DNA scission studies were observed by the plasmid
relaxation assay. Studies on physiological metabolic activation of 3-OHAA and AA in
the presence of copper were mimicked by using rat liver S9 fraction.
Materials and Methods
Reagents
All the chemicals AA, 3-OHAA, 4-Aminobiphenyl (4-Ab), dimethylsulfoxide
(DMSO), hydrogenperoxide (H2O2), nicotinamide adenine dinucleotide phosphate
monosodium salt (NADP), glucose-6-phosphate, mitomycin C (MMC),
ethelenediamintetraacetate (EDTA), ferrous sulphate (FeSO4), copper sulphate (CuSO4),
zinc sulphate (ZnSO4) and manganese chloride (MnCl3) were purchased from Sigma (St.
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Louis, MO). AA, 3-OHAA and MMC solutions were freshly dissolved in DMSO. FeSO4,
CuSO4, ZnSO4, MnCl3 solutions were made with distilled water. Oxoid nutrient broth no.
2 for culturing Salmonella typhimurium TA102 was obtained from BD Biosciences
(Sparks, MD). The Aroclor 1254-induced rat liver post mitochondrial supernatant S9 in
0.154 M KCl was purchased from Molecular Toxicolgy Inc. (Boone, NC).
Bacterial cultures and plasmids
Tester strain Salmonella typhimurium TA102 (TA102) was purchased from
Molecular Toxicology Inc. (Boone, NC). Stocks were prepared from overnight cultures
(12-13 hrs) grown in Oxoid broth no. 2 at 370 C. One ml aliquots of stock cultures were
prepared by adding DMSO as a cryoprotective agent to an overnight culture of TA102.
All the aliquots were snap-freezed on dry ice and stored at -80o C. The tester strain
TA102 was regularly monitored for phenotypic variations and viability as described in
Mortelmens et al. [2000]. The Plasmid PSP-72 used in the plasmid relaxation assay was
provided by Dr. Carlos Estraño, The University of Memphis.
Plasmid relaxation assay
All the metabolites were screened for mutagenic abilities using plasmid relaxation
assay as described in Falcioni et al., 2002. 100 ng of plasmid pSP-72 was incubated in
100 mM sodium phosphate buffer at pH 7.4 along with the test chemicals AA or 3OHAA at concentrations 50 µM, 100 µM, 150 µM, 200 µM and 400 µM. The respective
test chemical concentrations were also incubated with metal cofactors Fe (II), Cu (II), and
Mn (III) at concentrations 2.5 µM, 5µM, 10 µM, 15 µM, and 20 µM while checking for
metal mediated plasmid relaxation. The reaction mixture containing the chemical, metal
cofactor, plasmid and buffer were incubated in the dark at 370C for 2 hrs. After 2 hrs, the

6

reaction volume was mixed with 5 µl gel loading buffer and was loaded onto 0.7 %
agarose gel and electrophoresed at 80V for 1hr. The gels were loaded with plasmid DNA
in DMSO alone on the first well as a negative control. The second well was loaded with
plasmid DNA along with Fe (II) as the positive control [Flemmig and Arnhold, 2007].
The third well was generally loaded with test chemical without any metal cofactor along
with DNA. The rest of the wells 4th – 8th were loaded in the increasing order of the metal
cofactor (2.5 µM, 5µM, 10 µM, 15 µM, and 20 µM) and 100 µM test chemical or
increasing order of the test chemical (50 µM , 100 µM, 150 µM, 200 µM and 400 µM)
and 10 µM of metal cofactor along with DNA. The results were pictured using BIO-RAD
gel documentation system and analyzed using BIO-RAD Chemi-doc software (Bio-Rad
laboratories, Inc, USA).
Ames Salmonella/microsome mutagenicity assay
The Ames Salmonella mutagenicity assay was performed according to the preincubation protocol described by Maron and Ames, [1983]. The test samples that required
metabolic activation were incubated with Aroclor 1254-induced rat liver post
mitochondrial supernatant S9 as suggested in Mortelmans et al. [2000]. 50 µl of viable
TA102 was inoculated into 50 ml of Oxoid broth No.2 (25 gm in one L of distilled water)
and grown at 37 0 C on incubator-shaker at 160 RPM. The culture was grown for 12- 16
hrs until the required cell density of 1-2 x 109 cfu/ml was reached. The S9 mix required
for metabolic activation was freshly prepared by mixing one ml Aroclor 1254-induced rat
liver post mitochondrial supernatant S9 in 0.154 M KCl in nine ml of the S9 Cofactor
buffer (10% v/v) and filter sterilized through a 0.45 µm filter membrane. The freshly
prepared cofactor buffer contains 0.5 mM glucose-6-phosphate, 0.4 mM NADP, 0.8 mM
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MgCl2, 3.3 mM KCl, and 10 mM sodium phosphate at pH 7.4. Sterile glass tubes that
contained the reaction mixture, which include 500 µl 0.1M sodium phosphate buffer (pH
7.4) or the S9 mix, 50 µl of the test chemical solution, 50 µl of metal cofactor (CuSO4)
and 100 µl of TA102 were incubated at 370 C at 160 RPM on a shaker for 45 min. The
reaction mixture was then mixed with 2 ml of molten soft agar (6 g/L agar and 6 g/L
NaCl) with histidine (0.5 mM) at 480 C, vortexed and quickly spread uniformly on a
minimal glucose agar plate (GM agar plate). The plates were incubated at 370 C for 48
hrs and the numbers of revertants were counted on a colony counter. The test chemicals
AA, 3-OHAA, when tested alone were tested at concentrations of 5 µg through 250 µg (5
µg, 10 µg, 50 µg, 100 µg and 250 µg). The assay was performed at fixed concentrations
of 100 µg AA or 3-OHAA per plate when tested for metal mediated activation. The
concentrations of the Cu (II) were varied from 2.5 µg though 100 µg per plate (2.5 µg, 5
µg, 10 µg, 20 µg, 50 µg, 100 µg). The recommended positive control MMC for TA102
was used at a concentration of 0.5 µg per plate. 4-Aminobiphenyl was used as a positive
control for the metabolic activation in the presence of S9 mix. DMSO was used as a
negative control.
Statistical analysis
Each experiment was performed with three replicates (3 plates) for a particular
concentration or a given particular chemical. The statistical significance was calculated
by one way analysis of variance (ANOVA) using the program Graph pad prism. The
significant P-value was determined for the comparison among the experimental groups.
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Results
3-OHAA in the presence of Cu (II) induces DNA strand nicks in DNA
It has been reported that Fe (II) in the presence of serotonin causes DNA damage
by single stranded nicks [Hadi et al., 2001]. Previous studies in our lab have also
demonstrated that Fe (II) in the presence of benzidine (Bz) and 4-Ab was able to induce
DNA damage by causing nicks in a supercoiled plasmid (Makena and Chung unpublished
results). Spencer et al. [1994] reported that copper in the presence of L-dopa forms
DNA adducts. We have attempted here to demonstrate the metal mediated toxicity of 3OHAA. Cu (II) at increasing doses from 2.5 µM – 20 µM were incubated with 100 µM 3OHAA. We determined whether they caused DNA strand breaks in the supercoiled
plasmid pSP-72 (Fig 1). A nick in the supercoiled form of plasmid changed its
electrophoretic mobility and two bands of plasmid DNA could be observed if the test
chemical induced nicks in the plasmid. DMSO as a negative control did not show any
nicked form of the DNA (lane 1), and Fe (II) at 10 µM that showed a clear lag mobility
of the band was used as a positive control (lane 2). Five µM Cu (II) in presence of 3OHAA was able to induce nicks in the plasmid DNA; however, the nicked plasmid was
not clearly visible (lane 5). Copper at increased concentrations of 10 µM (lane 6), 15 µM
(lane 7), 20 µM (lane 8) in the presence of a 3-OHAA dose dependently increased the
amount of plasmid pSP-72 being nicked to the circular form and hence clearly showed an
receding band due to the slow mobility of the plasmid (Fig 1). The 3-OHAA at 100 µM
alone did not cause any change in position of the band (lane 3).
In order to understand the minimum concentration of 3-OHAA necessary for
causing the DNA damage in vitro, Cu (II) at 10 µM was incubated with increasing
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concentrations of 3-OHAA from 50 µM – 400 µM and observed for band shift (Fig. 2.).
50 µM of 3-OHAA in the presence of 10µM Cu (II) was able to cause a nick in the
plasmid; however all supercoiled DNA was not turned into circular plasmid (lane 4). An
increase in the concentration of 3-OHAA to 100 µM (lane 5), one hundred and fifty µM
(lane 6), 200 µM (lane 7) and 400 µM (lane 8) caused an apparent band shift by
converting almost all the supercoiled pSP-72 to circular nicked forms. The pSP-72
incubated with 10 µM Cu (II) alone did not show any DNA strand breaks (lane 3). An
increase in the Cu (II) concentration alone on pSP-72 from 1 µM though 20 µM also did
not show any DNA strand breaks, suggesting that Cu (II) alone cannot cause DNA
damage in vitro (Fig 3).
In contrast to 3-OHAA, AA in the presence of Cu (II) did not show any DNA
strand breaks in pSP-72 (Fig 4). These results suggest that Cu (II) at a concentration of 10
µM in the presence of 100 µM of 3-OHAA can induce DNA strand break in vitro.
3-OHAA and AA alone were not mutagenic to Salmonella TA102 with or without
activation by S9
Bowden et al. [1976] have tested the mutagenic effect of tryptophan metabolites
AA, 3-OHAA and other compounds with Salmonella tester strains TA1535, TA1537,
TA1538, TA98, TA100, but not TA102 and reported no significant mutagenic effect in
the presence or absence of S9. However, it was reported that AA and 3-OHAA were comutagenic in the presence of 2-aminoanthracene (2-AA) and S9 treatment. In the present
study, TA102 was employed in the Ames Salmonella/microsome mutagenicity assay to
evaluate the mutagenic effect of AA and 3-OHAA with and without S9 (Fig. 5 and 6). It
is important to test the mutagenic effects with TA102, because it is sensitive to oxidative
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mutagens; whereas, other strains are not particularly sensitive to them [Levin et al.,
1982]. Both AA and 3-OHAA were incubated with TA102 (at five concentrations of 5
µg, 10 µg, 50 µg, 100 µg, 250 µg/per plate) did not show any significant increase in
revertants when compared with the negative control DMSO (Fig. 5). MMC at 0.5 µg was
used as a positive control.
Anthranilic acid and 3-OHAA were also treated with aroclor induced rat liver S9
metabolic activation system, in the presence of NADP (S9 mix), at the concentrations 5
µg - 250 µg to test for production of oxidative mutagenic intermediates or radicals. No
significant difference in number of revertants was observed with reference to negative
control DMSO when treated with S9 mix (Fig. 6). We have used 4-Ab as a positive
control for metabolic activation of a test chemical in the presence of rat liver S9 mix as
previously reported from our lab [Makena and Chung, 2007].
3-OHAA in the presence of Cu (II) and absence of S9 was mutagenic to Salmonella
TA102
Previous studies in our lab suggest that the metal cofactor Fe (II) activates
benzidine and 4-Ab to cause a mutagenic effect on TA102. Hiramatsu et al. [2008]
reported that MnCl2 in the presence of 3-OHAA was able to induce apoptosis of cells by
generating reactive oxygen species (ROS). Serotonin was reported to interact with Cu (II)
in the cytosol to generate hydroxyl radicals. These hydroxyl radicals were generated by
the oxidation of phenolic group of serotonin [Hadi et al., 2002]. In the present study AA
and 3-OHAA at a concentration of 100 µg per plate were treated at six concentrations of
Cu (II) at 2.5 µg, 5 µg, 10 µg, 20 µg, 50 µg, 100 µg and incubated along with Salmonella
TA102. The 3-OHAA significantly increased the number of revertants per plate when
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treated at increasing concentrations of Cu (II) (Fig. 7). One hundred µg of 3-OHAA was
able to induce significant mutagenic effect at Cu (II) concentration as low as 5 µg (P <
0.05). An increase in the concentration of Cu (II) showed a significant dose response in
causing mutagenesis (Fig. 7). In contrast, AA in the presence of Cu (II) (at all
concentrations) did not induce any significant increase in the number of revertants per
plate compared to the negative control DMSO (Fig. 8). TA102 was also incubated with
only Cu (II) alone at all concentrations without AA or 3-OHAA to test whether Cu (II)
alone was able to induce any mutagenic effect. Cu (II) was unable to induce mutagenic
effect at all concentrations tested on TA102 (white plain bars in Fig. 7 and 8). Also, AA
and 3-OHAA at 100 µg were unable to induce mutagenic effect by themselves on TA102.
Mitomycin C at 0.5 µg was used as a positive control. Figure 9, shows a comparison of
mutagenic effect of AA and 3-OHAA on TA102.
3-OHAA in the presence of Cu (II) and S9 mix was not mutagenic to TA102
To check for physiological metabolic activation in the presence of Cu (II), both
AA and 3-OHAA were incubated with 5 µg, 20 µg, 100 µg of Cu (II) and S9. There was
no significant difference in the number of revertants per plate when both AA and 3OHAA were treated with S9 mix in the presence of Cu (II) (Fig. 10). 3-OHAA, which
was able to cause mutagenic effect without S9 (Fig. 9), was unable to show any
significant mutagenic effect in the presence of S9 (Fig. 10).
This demonstrates that the rat liver S9 might inhibit the oxidative stress induced by Cu
(II) in the presence of 3-OHAA on TA102 (Figs. 9 and 10).
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Discussion
Dietary compounds like food additives, cooked products of meat and fish,
phytoestrogens in plants, amino acids and their metabolites are implicated to induce
carcinogenesis by generating reactive oxygen species (ROS) [Ames BN, 1983; Klaunig et
al., 2011]. Bryan et al. [1964a-b] reported that tryptophan metabolites 3-OHAA and 3OHKN implanted in a cholesterol vehicle significantly induced bladder tumors in mice.
Fe (II) and Cu (II) interacting with serotonin, a tryptophan metabolite, induce DNA
cleavage [Hadi, 2002]. Tryptophan metabolism is associated with generation of
intermediate metabolite quinolinic acid which is neurotoxic. Quinolinic acid in the
presence of 2 µM Fe (II) concentration was able to induce lipid peroxidation in brain
homogenates of mice [Stipek et al., 1997; Johnson S, 2001]. Several studies have
reported that metal cofactor mediated toxicity of tryptophan metabolites in the serotonin
pathway but not nicotinamide pathway. In contrast to the toxicity caused by metabolites
in the serotonin pathway to brain tissue, metabolites in the nicotinamide pathway
including AA, 3-OHAA, 3-OHKN, KN might cause problems with liver, kidney and
bladder. In the present study, the electrophoresis data indicates that 100 µM of 3-OHAA
in the presence of Cu (II) concentration as low as 5 µM was able to induce DNA strand
breaks in the pSP-72 plasmid, whereas AA did not cause any effect.
L-DOPA (L-3,4-dihydroxyphenylalanine), an endogenous metabolite generated in
the dopamine synthesis, caused mutagenesis in the presence of Cu (II). Short lived OHradicals were generated through reduction of Cu (II) to Cu (I) in the presence of L-DOPA
which caused strand scission of DNA [Husain and Hadi, 1995]. Hiraku et al. [1999]
reported that aminoacetone generated during the threnonine and glycine metabolism
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interacted with Cu (II) to produce free hydroxyl radicals and damaged DNA at cytosine
and thymine residues. Alternatively, 3-OHAA could also be auto oxidized in the presence
of oxygen to generate 3-OHAA radical (anthranilyl radical), which is further oxidized to
quinonemine. Consequently, quinonemine is condensed along with another 3-OHAA
molecule in the presence of oxygen to generate cinnabarinic acid and hydrogen peroxide
[Dykens et al., 1987]. In the present study, Ames test data with Salmonella TA102
suggest that 3-OHAA is significantly mutagenic only in the presence of Cu (II) at
quantity as low as 5 µg/per plate. However, AA in the presence or absence of copper did
not result in any mutagenesis. It should be noted here that TA102 is an oxidative stresssensitive strain, and significant increase in its revertants is associated with oxidative
stress caused by test chemical 3-OHAA. Previous results from Bowden et al. [1976] had
no mutagenic effect because they used other Salmonella tester strains which were not
sensitive to ROS. In the present studies with TA102, 3-OHAA in presence of Cu (II),
causes mutagenesis in vitro by generating oxidative stress. Structurally, both AA and 3OHAA are almost similar except for the presence of an extra hydroxyl group at the ortho
position to amino group in 3-OHAA. The oxidative mutagenic effects of only 3-OHAA
in the presence of Cu (II) could be attributed to the functionality of this extra hydroxyl in
3-OHAA.
Physiologically, environmental contaminants are bioactivated either in the liver or
sometimes by resident bacteria in the intestines [Chung et al., 1975a-b]. Benzidine and 4Ab were metabolically activated by rat liver S9 mix (in the presence of NADP) to
mutagens by generating ROS [Makena and Chung, 2007]. Adris and Chung [2006] have
previously demonstrated that the bacterium Pseudomonas aeroginosa was able to activate
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2-aminoflourene, 4-Ab and benzidine to carcinogens. 3-OHAA and AA in presence rat
liver S9 mix alone were not mutagenic in Salmonella TA102 and hence they both are not
metabolically activated without the presence of metal cofactor Cu (II). However, it was
also observed here that the significant mutagenic effect of Cu (II) and 3-OHAA in TA102
without S9 mix discussed above was blunted when treated with S9 mix (reduction in the
number of revertants) in vitro. From the above results it could be interpreted that the toxic
effect of 3-OHAA and Cu (II) in liver could possibly be detoxified by the liver. However,
their presence in other tissues like kidney and bladder may apparently lead to
mutagenesis.
Lai et al. [2010] reported a significantly high increase in hepatic concentrations of
copper (40 % to control) in Sprague-Dawley rats when exposed to industrial toxicant 3,
3’, 4, 4’, 5-pentachlorobiphenyl (PCB 126). A similar study where Sprague-Dawley rats
were exposed to the environmental pollutant 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)
reported a 2-fold and 4-hold Cu (II) ion concentration increase in the liver and kidney
respectively [Elsenhans et al., 1991]. It was suggested that under excessive intake of
copper or circumstances of liver damage, excess Cu (II) is excreted by the kidneys into
the urinary bladder [Mahoney et al., 1955]. Teulings et al. [1978] reported that an
increased excretion of tryptophan metabolites, especially 3-OHAA and 3-OHKN
occurred in bladder and renal cancer patients. Several other animal studies have also
demonstrated involvement of tryptophan metabolites in bladder cancer; however, the
mechanism involved in carcinogenesis was not specified. Recently, Mazdak et al. [2010]
measured the serum concentrations of trace metal cofactors Cu (II), Zn (II), and Fe (II) in
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the bladder cancer patients and reported a significant increase in Cu (II) levels compared
to healthy individuals (P<0.001).
In agreement with the above reports, our results indicate interaction of both Cu
(II) and 3-OHAA during urinary excretion could generate oxidative stress that probably
plays a role in causing mutagenesis in bladder epithelial cells leading to bladder
carcinogenesis. Further in vivo research to evaluate the role of the metal cofactor Cu (II)
and the tryptophan metabolite 3-OHAA in causing bladder cancer is needed in support of
these in vitro findings.
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Chapter 3
Conclusion
The hypothesis for this work was based on several epidemiological studies that
reported an increased excretion of the tryptophan metabolites, especially anthranilic acid
(AA), 3-hydroxyanthanilic acid (3-OHAA), 3-hydroxykynurenine, and kynurenine in the
urine of bladder cancer patients [Teulings et al., 1978; Rose, 1972; Sidransky, 1997]. In
the current study, we evaluated two of these metabolites, anthranilic acid (AA), and 3hydroxyanthanilic acid (3-OHAA), for their mutagenic potential. This study also
demonstrates the effect of a metal cofactor particularly the copper (Cu (II)) on these
metabolites to cause mutagenesis.
Initially, the plasmid relaxation assay was employed using pSP-72 to observe
whether these compounds have the ability to cause any DNA damage. It was found that
both of the metabolites were unable to cause any DNA nicks in the supercoiled plasmid.
Subsequently, when these metabolites were incubated with the metal cofactor Cu (II), 3OHAA was able to cause DNA damage whereas Cu (II) with AA was unable to cause
DNA damage.
Further study, to understand the mechanism involved in the DNA damage was
performed using Ames Salmonella/microsome mutagenicity assay. Among the various
tester strains, a relatively new tester strain Salmonella TA102, sensitive to the oxidative
mutagens, was used in this assay to understand the underlying mechanism [Levin et al.,
1982]. TA102, used in this study, was not sensitive to both AA and 3-OHAA when
incubated alone. However, it was significantly sensitive to 3-OHAA in the presence of
metal cofactor Cu (II). Alternatively, there was no significant TA102 sensitivity in the
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presence of Cu (II) and AA. It was previously reported by Bowden et al. [1976] that both
AA and 3-OHAA were not mutagenic when tested with other strains TA1538, TA98,
TA100. These distinct results in the present study were attributed to the sensitivity of
TA102 to oxidative stress; whereas, the previous strains were insensitive. The results
thereby implicate that 3-OHAA in the presence of metal cofactor Cu (II) causes oxidative
stress-induced mutagenicity.
Consequently, to demonstrate physiological relevance, the mixtures of Cu (II) and
compound (AA and 3-OHAA) were treated with rat liver S9 (S9) to check the
detoxification ability of the liver. It was observed that, in the presence of S9, the
demonstrated mutagenic effect by Cu (II) and 3-OHAA was nullified. Although these
results imply that the liver detoxifies the oxidative stress, it is also important to note that
3-OHAA is not only localized in liver, but present in various other organs like the bladder
and kidney which do not have any detoxifying enzymes [Watanabe, 1978].
In summary, this study finds that 3-OHAA, in the presence of the metal cofactor copper
causes oxidative stress that damages DNA. This signifies that the accumulation of excess
3-OHAA and Cu (II) in the urinary bladder [Mahoney et al., 1955] might lead to
mutagenesis by causing oxidative stress and hence plays a role in the etiology of the
bladder cancer.
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APPENDIX
A. Figures

Fig. 1. Plasmid relaxation assay of Cu (II) and 3-hydroxyanthranilic acid (3-OHAA)
with change in concentrations of Cu (II). Plasmid pSP-72 was incubated with 100 µM 3OHAA at various concentrations of Cu (II) (2.5 µM – 20 µM). Lane 1 is a negative
control with DMSO, lane 2 is positive control with 10 µM Fe (II) and lane 3 is 100 µM 3OHAA only. Lanes 4-8 show effect of varying concentration of Cu (II) at 2.5 µM, 5 µM,
10 µM, 15 µM, 20 µM and 100 µM 3-OHAA respectively on pSP-72.
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Fig. 2. Plasmid relaxation assay of Cu (II) and 3-hydroxyanthranilic acid (3-OHAA) with

change in concentration of 3-OHAA. Plasmid pSP-72 was incubated with 10 µM Cu (II)
at various concentrations of 3-OHAA (50 µM – 400 µM). Lane 1 is a negative control
with DMSO, lane 2 is positive control with 10 µM Fe (II) and lane 3 is 10 µM Cu (II)
only. Lanes 4-8 show effect of varying concentration of 3-OHAA at 50 µM, 100 µM, 150
µM, 200 µM, 400 µM and 10 µM Cu (II) respectively on PSP-72.
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Fig. 3. Plasmid relaxation assay at various concentrations Cu (II) only. Lane 1 is a
negative control with DMSO, lane 2 is a positive control with 10 µM Fe (II). Lanes 3-8
show effects of varying concentrations of Cu (II) at 1 µM, 2.5 µM, 5 µM, 10 µM, 15 µM
and 20 µM respectively on pSP-72.
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Fig. 4. Plasmid relaxation assay of anthranilic acid (AA) and 3-hydroxyanthranilic acid
(3-OHAA) in the presence of Cu (II). Lanes 1-6 show the effect of 100 µM AA at various
concentrations of Cu (II) (1 µM – 20 µM) on pSP-72. Lane 7 is pSP-72 with 100 µM of
AA only. Lane 8 is pSP-72 only. Lane 9 is the positive control 10 µM Fe (II) in presence
of pSP-72. Lane 10 is pSP-72 with DMSO as negative control. Lane 11 is 3-OHAA only
with pSP-72. Lanes 12 -17 show the effect of 100 µM 3-OHAA at various concentrations
of Cu (II) (1 µM – 20 µM) on pSP-72.
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Effect of anthranilic acid and 3-hydroxyanthranilic acid in absence of S9
on TA 102

***
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MMC (0.5 g/plate) (positive control)
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Fig. 5. The mutagenic effect of anthranilic acid (AA) and 3-hydroxyanthranilic acid (3OHAA) without any S9 metabolic activation on ROS sensitive TA102. DMSO is the
negative control and MMC is the positive control. (***) indicates P<0.001 with reference
to the negative control DMSO.
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Effect of anthranilic acid and 3-hydroxyanthranilic acid in presence of
S9 on TA 102
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Fig. 6. The mutagenic effect of anthranilic acid (AA) and 3-hydroxyanthranilic acid (3OHAA) with S9 metabolic activation on ROS sensitive Salmonella TA102. DMSO is the
negative control and 4-Ab is the positive control. (***) indicates P<0.001 with reference
to the negative control DMSO.
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Effect of copper and 3-hydroxyanthranilic acid on TA102
5000
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Fig. 7. The mutagenic effect of 3-hydroxyanthranilic acid (3-OHAA) in presence of
Cu (II) without any metabolic activation, on ROS sensitive Salmonella TA102. DMSO is
the negative control and MMC is the positive control. (***) indicates P<0.001 with
reference to the negative control DMSO. (*) and (**) indicate P<0.05 and P<0.01
respectively with reference to the negative control DMSO. (#) indicates P<0.001 with
reference to 100 µg of Cu (II) only.
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Effect of copper and anthranilic acidon TA102
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Fig. 8. The mutagenic effect of anthranilic acid (AA) in presence of Cu (II) without any
metabolic activation on ROS sensitive Salmonella TA102. DMSO is the negative control
and MMC is the positive control. (***) indicates P<0.001 with reference to the negative
control DMSO.
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Comparative mutagenic effect of anthranilic acid and 3-hydroxyanthranilic acid in presence of
copper
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Fig. 9. Comparative mutagenic effects of 3-hydroxyanthranilic acid (3-OHAA) and
anthranilic acid (AA) in the presence of Cu (II) without any metabolic activation on ROS
sensitive Salmonella TA102. DMSO is the negative control and MMC is the positive
control. (***) indicates P<0.001 with reference to the negative control DMSO. (*) and
(**) indicate P<0.05 and P<0.01 respectively with reference to the negative control
DMSO. (#) indicates P<0.001 with reference to 100 µg of Cu (II) only.
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Comparative effect of anthranilic acid and 3-hydroxyanthranilic acid in presence
of S9 and copper
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Fig. 10. Comparative mutagenic effects of 3-hydroxyanthranilic acid (3-OHAA) and
anthranilic acid (AA) in the presence of Cu (II) with S9 metabolic activation on ROS
sensitive TA102. DMSO is the negative control and 4-Ab is the positive control. (***)
indicates P<0.001 with reference to the negative control DMSO.
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